Pankaj Pandey from ICICI Securities highlights five stocks poised for long-term growth, including Kaynes Technology and Data Patterns, backed by robust fundamentals and strategic investments.
Unresolved compliance issues at a manufacturing plant operated by Novo Nordisk have led to a complete response letter for Scholar Rock's lead drug for spinal muscular atrophy (SMA). The CRL is related ...